FDA User Fee Legislation Heads Toward Finish Line
European Medicines Agency Under Attack
European Parliament voted against clearing the agency's accounts because of management concerns.
Quintiles 2012 New Health Report
House Under Pressure to Act on FDA User Fee Legislation Following Speedy Senate Approval
A New Start to Anti-Infective Research?
Clayton Christensen on the Future of Pharma
Too Much Sauce Hollandaise? Pharma, France, and Socialism
Parallel Trade Fuels UK Drug Shortages
Pediatric Trials: Past and Future
Key Updates to the 1572
NIH Scientists Hope to Teach Old Drugs New Tricks
Interview Outtakes
Jane Ganter: A Look Back at ACT
Can Trial Monitoring Be Changed?
No One Said Partnering Would Be Easy
Applied Clinical Trials Anniversary
Drug Shortages Still in Focus
Drug Safety Directions Forum
Divergences as Europe Tightens Its Rules on Drug Withdrawals
What is ClinicalTrials.gov's Destiny?
CETP Inhibitors: Blockbusters that Never Ran?
The Increasing Role of Biosimilars
Research Shows Most Clinical Trials are Too Small and Missing Data
A Few Comments on the Comments
US Biosimilars Under Threat?
Ethics is all the Rage in Europe
Clinical trials should meet ethical and GCP standards no matter where in the world they are conducted.
Europe Gets Serious About Geriatric Trials
Deborah Lasher Talks Mentoring
A Cautionary Note For Developers of Personalized Medicine
Gravy for the Rich, Blame for the Poor
